Recent research published in Communications Biology marks an advance in structural biology by enhancing understanding of ...
Pre-clinical data shows potential for FASN inhibition as mechanism of action to treat acne Phase 3 clinical trial of denifanstat in moderate to ...
Researchers have uncovered a previously hidden layer of complexity in how genes are activated, showing that water molecules ...
A new study shows exercise releases a liver enzyme that repairs aging brain blood vessels and restores memory.
For decades, circular RNA was treated as little more than molecular background noise — stable fragments that accumulated in ...
Targeted protein degradation has become one of the most promising strategies in modern drug discovery, enabling scientists to ...
A long-forgotten drug shows promise for children with a rare disease, offering hope for treatment where none previously ...
A preclinical study has developed a strategy that enables the forced elimination of proteins that help tumors survive ...
Morning Overview on MSN
Scientists may have found a way to slow Parkinson’s by strengthening the brain’s own protective systems instead of just treating symptoms
Every drug approved for Parkinson’s disease does the same thing: it manages symptoms. None slows the underlying destruction ...
A new study from Karolinska Institutet shows that an enzyme in the liver may partly explain sex differences in the body's ...
ATOS READ THE FULL ATOS RESEARCH REPORT We are initiating coverage of Atossa Therapeutics, Inc. (NASDAQ:ATOS) with a valuation of $22.00. Atossa is a clinical-stage biopharmaceutical company that is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results